Greenwich LifeSciences, Inc. (GLSI)

USD 12.28

(-5.61%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 3612.00 3612.00 3612.00 3609.00 3607.00 3607.00
Gross Profit -3612.00 -3612.00 -3612.00 -3609.00 -3607.00 -3607.00
Operating Expenses 9.32 Million 8.04 Million 4.59 Million 1.86 Million 3.42 Million 1.68 Million
Selling, General and Administrative Expenses 1.62 Million 1.56 Million 1.03 Million 806.18 Thousand 818.88 Thousand 419.63 Thousand
Research and Development Expenses 7.69 Million 6.47 Million 3.55 Million 1.05 Million 2.6 Million 1.27 Million
Other Expenses - - - - - -
Cost and Expenses 9.32 Million 8.04 Million 4.59 Million 1.86 Million 3.42 Million 1.68 Million
Operating Income -9.32 Million -8.04 Million -4.59 Million -1.86 Million -3.42 Million -1.68 Million
Interest Expense - - - - - -
Income Tax Expense - -215.01 Thousand -27.36 Thousand -832.00 3.00 -157.53 Thousand
Earnings before Tax -8.89 Million -7.82 Million -4.57 Million -1.86 Million -3.42 Million -1.68 Million
Net Income -8.89 Million -7.61 Million -4.54 Million -1.86 Million -3.42 Million -1.68 Million
Earnings Per Share Basic -0.69 -0.59 -0.35 -0.15 -0.29 -0.14
Earnings Per Share Diluted -0.69 -0.59 -0.35 -0.15 -0.29 -0.14
Weighted Average Shares Outstanding 12.84 Million 12.91 Million 12.94 Million 12.7 Million 11.74 Million 11.97 Million
Weighted Average Shares Outstanding (Diluted) 12.84 Million 12.91 Million 12.94 Million 12.7 Million 11.74 Million 11.97 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -9.32 Million -8.03 Million -4.59 Million -1.86 Million -3.42 Million -1.68 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts